SoMS Honours
Potential Projects » Metabolism & Energy
| Academic | Project Title |
|
Prof Sally Dunwoodie & Dr Gavin Chapman Victor Chang Cardiac Research Institute |
Genetics, Embryology, Imaging, Metabolomics: Explore how NAD deficiency causes birth defects and how niacin/vitamin B3 supplementation prevents deficiency and defects |
|
Prof Sally Dunwoodie & Dr Hartmut Cuny Victor Chang Cardiac Research Institute |
Genetics, Gene-Environment Interaction and Embryology: NAD Deficiency, Congenital Malformation and Vitamin B3 Supplementation |
|
Prof Emad El-Omar & Dr Xiaotao Jiang Microbiome Research Centre, St George and Sutherland Clinical School |
The healthy optimal Australian microbiome (HOAM) study |
|
Garvan Institute of Medical Research |
How does diabetes promote neurodegeneration? |
|
Prof Margaret Morris & Dr Ria Arnold SoMS |
How does diet affect the pancreas and kidney in a rodent model of type 2 diabetes? |
|
Dr Chris Maloney, Dr Virginie Lecomte & Prof Margaret Morris |
Can folate supplementation reduce the impact of paternal obesity? |
|
Lipid Research Group, SoMS |
Role of fibroblast growth factor 21 in pregnancy-induced insulin resistance |
|
Prof Mike Rogers & Dr Marcia Munoz Garvan Institute of Medical Research |
The role of the mevalonate-cholesterol pathway in childhood inflammatory disease |
|
Lipid Research Group, SoMS |
Diabetes and Cardiovascular Disease |
|
Garvan Institute of Medical Research |
Investigating how neuropeptide Y (NPY)-Y1 receptor signalling controls insulin secretion in pancreatic islets in obesity and diabetes |
|
Garvan Institute of Medical Research |
Targeting neuropeptide Y (NPY) signalling in adipose tissue to promotor thermogenesis and weight loss |
|
Garvan Institute of Medical Research |
Coordinated control of appetite and insulin release by the gut-hormone PYY and GLP1 in obese and type 2 diabetes |
|
A/Prof Carsten Schmitz-Peiffer Garvan Institute of Medical Research |
Targeting Protein Kinase C epsilon for the Treatment of Type 2 Diabetes |
|
Department of Pharmacology, SoMS |
Glucose regulation of cellular signalling events in the liver
|
|
Department of Pharmacology, SoMS |
Phosphatidylinositol 3-kinase signalling in the liver |
|
Victor Chang Cardiac Research Institute |
New ways to regulate cellular and mitochondrial content of coenzyme Q as a potential treatment of insulin resistance, diabetes and atherosclerosis |
|
Dr Fatiha Tabet & Dr Kwok Leung Ong Lipid Research Group, SoMS |
Relationship of HDL-associated microRNAs with early stage cardiovascular disease in patients with type 2 diabetes |
|
Investigating the role of a novel receptor protein in mediating the beneficial metabolic effects of medium chain fatty acids
|
|
| Targeting of lipid synthesis pathways to improve glucose metabolism in obesity | |
|
A/Prof Alexander Viardot & Prof Lesley Campbell Garvan Institute of Medical Research |
Mechanisms of a novel therapeutic agent on appetite, weight, gastric emptying and cognition in the genetic obesity disorder Prader Willi syndrome |
|
Targeting cellular senescence to treat ageing and the side effects of common drugs |
|
|
Treating cancer by reversing metabolic aging |
|
|
Near infrared light therapy as an exercise mimetic for inducing mitochondrial stress and extending lifespan |
|
|
St George and Sutherland Clinical School |
Role of the gut micro biome in liver inflammation and liver cancer in obesity |